Bioverativ
ENJAYMO
Manufacturer:
Bioverativ
Name:
ENJAYMO
HCPCS Code Descriptor:
Inj, sutimlimab-jome, 10 mg
Category:
C Code
HCPCS:
C9094
NDC(s):
80203-0347-01
Primary Type:
Hematology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
ENJAYMO is a Hematology drug manufactured by Bioverativ and administered via the Intravenous route of administration. The C Code: C9094 is aligned to the drug ENJAYMO.
Access Pricing and More By Registering
HCPCS Added Date:
7/1/22
HCPCS Effective Date:
10/1/22
HCPCS Short Description:
Inj, sutimlimab-jome, 10 mg
Billing and Coding Guide:
Not Found
Patient Assistance:
Not Found
